We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

711 hedge funds and large institutions have $17.9B invested in Exact Sciences in 2025 Q4 according to their latest regulatory filings, with 254 funds opening new positions, 152 increasing their positions, 215 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

925% more funds holding in top 10

Funds holding in top 10: 441 (+37)

159% more first-time investments, than exits

New positions opened: 254 | Existing positions closed: 98

84% more capital invested

Capital invested by funds: $9.7B → $17.9B (+$8.18B)

75% more call options, than puts

Call options by funds: $359M | Put options by funds: $205M

25% more funds holding

Funds holding: 569711 (+142)

0.64% less ownership

Funds ownership: 93.65%93.01% (-0.64%)

29% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 215

Holders
711
Holders Change
+142
Holders Change %
+24.96%
% of All Funds
8.63%
Holding in Top 10
41
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+925%
% of All Funds
0.5%
New
254
Increased
152
Reduced
215
Closed
98
Calls
$359M
Puts
$205M
Net Calls
+$154M
Net Calls Change
+$124M
Name Holding Trade Value Shares
Change
Change in
Stake
TGIA
301
Torrey Growth & Income Advisors
California
$1.54M -$994K -12,380 -45%
FDCDDQ
302
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.5M +$169K +2,100 +17%
QCM
303
QRG Capital Management
Illinois
$1.48M +$232K +2,888 +25%
AFAS
304
Acorn Financial Advisory Services
Virginia
$1.48M -$13.2K -164 -1%
CF
305
Cantor Fitzgerald
New York
$1.48M +$1.17M +14,566 New
VOYA Investment Management
306
VOYA Investment Management
Georgia
$1.42M -$136K -1,696 -11%
CB
307
Commerce Bank
Missouri
$1.41M +$1.53K +19 +0.1%
EWA
308
Exencial Wealth Advisors
Oklahoma
$1.41M +$1.12M +13,912 New
HI
309
Harbour Investments
Wisconsin
$1.41M -$579K -7,215 -34%
AF
310
Advisornet Financial
Minnesota
$1.4M -$221K -2,757 -17%
FC
311
FORA Capital
Florida
$1.38M +$358K +4,457 +49%
GCM
312
Greenland Capital Management
New York
$1.38M +$1.09M +13,602 New
BIG
313
Brooklyn Investment Group
New York
$1.36M +$1.07M +13,381 New
CAM
314
Cresset Asset Management
Illinois
$1.34M -$145K -1,810 -12%
Two Sigma Advisers
315
Two Sigma Advisers
New York
$1.32M +$1.04M +12,956 New
KC
316
Kintayl Capital
New York
$1.3M +$1.03M +12,847 New
Axa
317
Axa
France
$1.3M -$176K -2,195 -15%
Mirae Asset Global ETFs Holdings
318
Mirae Asset Global ETFs Holdings
Hong Kong
$1.29M -$318K -3,960 -24%
CC
319
Chicago Capital
Illinois
$1.28M -$8.43K -105 -0.8%
HIP
320
HUB Investment Partners
Texas
$1.28M +$562 +7 +0.1%
SA
321
Sanctuary Advisors
Indiana
$1.28M +$186K +2,315 +23%
PWM
322
Perigon Wealth Management
California
$1.28M +$68.1K +848 +7%
IWC
323
Integrated Wealth Concepts
Massachusetts
$1.27M +$364K +4,538 +57%
IP
324
Isthmus Partners
Wisconsin
$1.25M +$6.91K +86 +0.7%
OSAM
325
O'Shaughnessy Asset Management
Connecticut
$1.24M +$167K +2,077 +20%

EXAS Hedge Fund Activity: Q4 2025 in Review

711 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2025, worth a combined $17.9B — up 84% from $9.7B a quarter earlier.

Buyers outnumbered sellers: 254 funds opened new EXAS positions and 98 closed out — a net gain of 156 holders — while 152 added to existing stakes and 215 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $614M. The largest seller was Fidelity Investments, cutting an estimated $1.41B.

  • 711 institutional investors held Exact Sciences (EXAS) as of Q4 2025, up from 569 in Q3 2025.
  • Funds reported $17.9B of Exact Sciences stock for Q4 2025, up 84% quarter-over-quarter.
  • 254 funds opened new Exact Sciences positions in Q4 2025 and 98 closed out, a net change of +156 holders.
  • The largest Exact Sciences buyer in Q4 2025 was HBK Investments, an estimated $614M added.
  • The largest Exact Sciences seller in Q4 2025 was Fidelity Investments, an estimated $1.41B sold.

Based on aggregated 13F filings for Q4 2025.